Medical Care
Global Blood Product Market Research Report 2024
- Jan 26, 24
- ID: 42636
- Pages: 100
- Figures: 213
- Views: 24
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The global Blood Product market was valued at US$ 28320 million in 2023 and is anticipated to reach US$ 47570 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.
This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
Report Scope
The Blood Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Segment by Type
Albumin
Immunoglobulin
Clotting Factor
Others
Segment by Application
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Blood Product market was valued at US$ 28320 million in 2023 and is anticipated to reach US$ 47570 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.
This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
Report Scope
The Blood Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Segment by Type
Albumin
Immunoglobulin
Clotting Factor
Others
Segment by Application
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Product Market Perspective (2019-2030)
2.2 Blood Product Growth Trends by Region
2.2.1 Global Blood Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Product Historic Market Size by Region (2019-2024)
2.2.3 Blood Product Forecasted Market Size by Region (2025-2030)
2.3 Blood Product Market Dynamics
2.3.1 Blood Product Industry Trends
2.3.2 Blood Product Market Drivers
2.3.3 Blood Product Market Challenges
2.3.4 Blood Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Product Players by Revenue
3.1.1 Global Top Blood Product Players by Revenue (2019-2024)
3.1.2 Global Blood Product Revenue Market Share by Players (2019-2024)
3.2 Global Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Product Revenue
3.4 Global Blood Product Market Concentration Ratio
3.4.1 Global Blood Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Product Revenue in 2023
3.5 Blood Product Key Players Head office and Area Served
3.6 Key Players Blood Product Product Solution and Service
3.7 Date of Enter into Blood Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Product Breakdown Data by Type
4.1 Global Blood Product Historic Market Size by Type (2019-2024)
4.2 Global Blood Product Forecasted Market Size by Type (2025-2030)
5 Blood Product Breakdown Data by Application
5.1 Global Blood Product Historic Market Size by Application (2019-2024)
5.2 Global Blood Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Product Market Size (2019-2030)
6.2 North America Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Product Market Size by Country (2019-2024)
6.4 North America Blood Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Product Market Size (2019-2030)
7.2 Europe Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Product Market Size by Country (2019-2024)
7.4 Europe Blood Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Product Market Size (2019-2030)
8.2 Asia-Pacific Blood Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Product Market Size (2019-2030)
9.2 Latin America Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Product Market Size by Country (2019-2024)
9.4 Latin America Blood Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Product Market Size (2019-2030)
10.2 Middle East & Africa Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Product Introduction
11.1.4 Takeda Revenue in Blood Product Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Blood Product Introduction
11.2.4 CSL Revenue in Blood Product Business (2019-2024)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Product Introduction
11.3.4 Grifols Revenue in Blood Product Business (2019-2024)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Product Introduction
11.4.4 Octapharma Revenue in Blood Product Business (2019-2024)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Product Introduction
11.5.4 Kedrion Revenue in Blood Product Business (2019-2024)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Product Introduction
11.6.4 LFB Group Revenue in Blood Product Business (2019-2024)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Product Introduction
11.7.4 Biotest Revenue in Blood Product Business (2019-2024)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Blood Product Introduction
11.8.4 BPL Revenue in Blood Product Business (2019-2024)
11.8.5 BPL Recent Development
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Detail
11.9.2 Shanghai RAAS Business Overview
11.9.3 Shanghai RAAS Blood Product Introduction
11.9.4 Shanghai RAAS Revenue in Blood Product Business (2019-2024)
11.9.5 Shanghai RAAS Recent Development
11.10 China Biologic Products
11.10.1 China Biologic Products Company Detail
11.10.2 China Biologic Products Business Overview
11.10.3 China Biologic Products Blood Product Introduction
11.10.4 China Biologic Products Revenue in Blood Product Business (2019-2024)
11.10.5 China Biologic Products Recent Development
11.11 Hualan Biological Engineering Inc.
11.11.1 Hualan Biological Engineering Inc. Company Detail
11.11.2 Hualan Biological Engineering Inc. Business Overview
11.11.3 Hualan Biological Engineering Inc. Blood Product Introduction
11.11.4 Hualan Biological Engineering Inc. Revenue in Blood Product Business (2019-2024)
11.11.5 Hualan Biological Engineering Inc. Recent Development
11.12 Beijing Tiantan Biological Products Corp
11.12.1 Beijing Tiantan Biological Products Corp Company Detail
11.12.2 Beijing Tiantan Biological Products Corp Business Overview
11.12.3 Beijing Tiantan Biological Products Corp Blood Product Introduction
11.12.4 Beijing Tiantan Biological Products Corp Revenue in Blood Product Business (2019-2024)
11.12.5 Beijing Tiantan Biological Products Corp Recent Development
11.13 Pacific Shuanglin
11.13.1 Pacific Shuanglin Company Detail
11.13.2 Pacific Shuanglin Business Overview
11.13.3 Pacific Shuanglin Blood Product Introduction
11.13.4 Pacific Shuanglin Revenue in Blood Product Business (2019-2024)
11.13.5 Pacific Shuanglin Recent Development
11.14 Boya Bio-Pharmaceutical
11.14.1 Boya Bio-Pharmaceutical Company Detail
11.14.2 Boya Bio-Pharmaceutical Business Overview
11.14.3 Boya Bio-Pharmaceutical Blood Product Introduction
11.14.4 Boya Bio-Pharmaceutical Revenue in Blood Product Business (2019-2024)
11.14.5 Boya Bio-Pharmaceutical Recent Development
11.15 Paisi Feike Biology Pharmacy Co., Ltd.
11.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Detail
11.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
11.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Introduction
11.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Revenue in Blood Product Business (2019-2024)
11.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
11.16 Xinjiang Deyuan Bioengineering
11.16.1 Xinjiang Deyuan Bioengineering Company Detail
11.16.2 Xinjiang Deyuan Bioengineering Business Overview
11.16.3 Xinjiang Deyuan Bioengineering Blood Product Introduction
11.16.4 Xinjiang Deyuan Bioengineering Revenue in Blood Product Business (2019-2024)
11.16.5 Xinjiang Deyuan Bioengineering Recent Development
11.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
11.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Detail
11.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
11.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Introduction
11.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue in Blood Product Business (2019-2024)
11.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
11.18 Shenzhen Weiguang
11.18.1 Shenzhen Weiguang Company Detail
11.18.2 Shenzhen Weiguang Business Overview
11.18.3 Shenzhen Weiguang Blood Product Introduction
11.18.4 Shenzhen Weiguang Revenue in Blood Product Business (2019-2024)
11.18.5 Shenzhen Weiguang Recent Development
11.19 Shanxi Kangbao
11.19.1 Shanxi Kangbao Company Detail
11.19.2 Shanxi Kangbao Business Overview
11.19.3 Shanxi Kangbao Blood Product Introduction
11.19.4 Shanxi Kangbao Revenue in Blood Product Business (2019-2024)
11.19.5 Shanxi Kangbao Recent Development
11.20 Nanyue Biopharming Corporation Ltd
11.20.1 Nanyue Biopharming Corporation Ltd Company Detail
11.20.2 Nanyue Biopharming Corporation Ltd Business Overview
11.20.3 Nanyue Biopharming Corporation Ltd Blood Product Introduction
11.20.4 Nanyue Biopharming Corporation Ltd Revenue in Blood Product Business (2019-2024)
11.20.5 Nanyue Biopharming Corporation Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Product Market Perspective (2019-2030)
2.2 Blood Product Growth Trends by Region
2.2.1 Global Blood Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Product Historic Market Size by Region (2019-2024)
2.2.3 Blood Product Forecasted Market Size by Region (2025-2030)
2.3 Blood Product Market Dynamics
2.3.1 Blood Product Industry Trends
2.3.2 Blood Product Market Drivers
2.3.3 Blood Product Market Challenges
2.3.4 Blood Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Product Players by Revenue
3.1.1 Global Top Blood Product Players by Revenue (2019-2024)
3.1.2 Global Blood Product Revenue Market Share by Players (2019-2024)
3.2 Global Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Product Revenue
3.4 Global Blood Product Market Concentration Ratio
3.4.1 Global Blood Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Product Revenue in 2023
3.5 Blood Product Key Players Head office and Area Served
3.6 Key Players Blood Product Product Solution and Service
3.7 Date of Enter into Blood Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Product Breakdown Data by Type
4.1 Global Blood Product Historic Market Size by Type (2019-2024)
4.2 Global Blood Product Forecasted Market Size by Type (2025-2030)
5 Blood Product Breakdown Data by Application
5.1 Global Blood Product Historic Market Size by Application (2019-2024)
5.2 Global Blood Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Product Market Size (2019-2030)
6.2 North America Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Product Market Size by Country (2019-2024)
6.4 North America Blood Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Product Market Size (2019-2030)
7.2 Europe Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Product Market Size by Country (2019-2024)
7.4 Europe Blood Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Product Market Size (2019-2030)
8.2 Asia-Pacific Blood Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Product Market Size (2019-2030)
9.2 Latin America Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Product Market Size by Country (2019-2024)
9.4 Latin America Blood Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Product Market Size (2019-2030)
10.2 Middle East & Africa Blood Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Product Introduction
11.1.4 Takeda Revenue in Blood Product Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Blood Product Introduction
11.2.4 CSL Revenue in Blood Product Business (2019-2024)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Product Introduction
11.3.4 Grifols Revenue in Blood Product Business (2019-2024)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Product Introduction
11.4.4 Octapharma Revenue in Blood Product Business (2019-2024)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Product Introduction
11.5.4 Kedrion Revenue in Blood Product Business (2019-2024)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Product Introduction
11.6.4 LFB Group Revenue in Blood Product Business (2019-2024)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Product Introduction
11.7.4 Biotest Revenue in Blood Product Business (2019-2024)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Blood Product Introduction
11.8.4 BPL Revenue in Blood Product Business (2019-2024)
11.8.5 BPL Recent Development
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Detail
11.9.2 Shanghai RAAS Business Overview
11.9.3 Shanghai RAAS Blood Product Introduction
11.9.4 Shanghai RAAS Revenue in Blood Product Business (2019-2024)
11.9.5 Shanghai RAAS Recent Development
11.10 China Biologic Products
11.10.1 China Biologic Products Company Detail
11.10.2 China Biologic Products Business Overview
11.10.3 China Biologic Products Blood Product Introduction
11.10.4 China Biologic Products Revenue in Blood Product Business (2019-2024)
11.10.5 China Biologic Products Recent Development
11.11 Hualan Biological Engineering Inc.
11.11.1 Hualan Biological Engineering Inc. Company Detail
11.11.2 Hualan Biological Engineering Inc. Business Overview
11.11.3 Hualan Biological Engineering Inc. Blood Product Introduction
11.11.4 Hualan Biological Engineering Inc. Revenue in Blood Product Business (2019-2024)
11.11.5 Hualan Biological Engineering Inc. Recent Development
11.12 Beijing Tiantan Biological Products Corp
11.12.1 Beijing Tiantan Biological Products Corp Company Detail
11.12.2 Beijing Tiantan Biological Products Corp Business Overview
11.12.3 Beijing Tiantan Biological Products Corp Blood Product Introduction
11.12.4 Beijing Tiantan Biological Products Corp Revenue in Blood Product Business (2019-2024)
11.12.5 Beijing Tiantan Biological Products Corp Recent Development
11.13 Pacific Shuanglin
11.13.1 Pacific Shuanglin Company Detail
11.13.2 Pacific Shuanglin Business Overview
11.13.3 Pacific Shuanglin Blood Product Introduction
11.13.4 Pacific Shuanglin Revenue in Blood Product Business (2019-2024)
11.13.5 Pacific Shuanglin Recent Development
11.14 Boya Bio-Pharmaceutical
11.14.1 Boya Bio-Pharmaceutical Company Detail
11.14.2 Boya Bio-Pharmaceutical Business Overview
11.14.3 Boya Bio-Pharmaceutical Blood Product Introduction
11.14.4 Boya Bio-Pharmaceutical Revenue in Blood Product Business (2019-2024)
11.14.5 Boya Bio-Pharmaceutical Recent Development
11.15 Paisi Feike Biology Pharmacy Co., Ltd.
11.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Detail
11.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
11.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Introduction
11.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Revenue in Blood Product Business (2019-2024)
11.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
11.16 Xinjiang Deyuan Bioengineering
11.16.1 Xinjiang Deyuan Bioengineering Company Detail
11.16.2 Xinjiang Deyuan Bioengineering Business Overview
11.16.3 Xinjiang Deyuan Bioengineering Blood Product Introduction
11.16.4 Xinjiang Deyuan Bioengineering Revenue in Blood Product Business (2019-2024)
11.16.5 Xinjiang Deyuan Bioengineering Recent Development
11.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
11.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Detail
11.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
11.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Introduction
11.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue in Blood Product Business (2019-2024)
11.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
11.18 Shenzhen Weiguang
11.18.1 Shenzhen Weiguang Company Detail
11.18.2 Shenzhen Weiguang Business Overview
11.18.3 Shenzhen Weiguang Blood Product Introduction
11.18.4 Shenzhen Weiguang Revenue in Blood Product Business (2019-2024)
11.18.5 Shenzhen Weiguang Recent Development
11.19 Shanxi Kangbao
11.19.1 Shanxi Kangbao Company Detail
11.19.2 Shanxi Kangbao Business Overview
11.19.3 Shanxi Kangbao Blood Product Introduction
11.19.4 Shanxi Kangbao Revenue in Blood Product Business (2019-2024)
11.19.5 Shanxi Kangbao Recent Development
11.20 Nanyue Biopharming Corporation Ltd
11.20.1 Nanyue Biopharming Corporation Ltd Company Detail
11.20.2 Nanyue Biopharming Corporation Ltd Business Overview
11.20.3 Nanyue Biopharming Corporation Ltd Blood Product Introduction
11.20.4 Nanyue Biopharming Corporation Ltd Revenue in Blood Product Business (2019-2024)
11.20.5 Nanyue Biopharming Corporation Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Clotting Factor
Table 5. Key Players of Others
Table 6. Global Blood Product Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Blood Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Blood Product Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Blood Product Market Share by Region (2019-2024)
Table 10. Global Blood Product Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Blood Product Market Share by Region (2025-2030)
Table 12. Blood Product Market Trends
Table 13. Blood Product Market Drivers
Table 14. Blood Product Market Challenges
Table 15. Blood Product Market Restraints
Table 16. Global Blood Product Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Blood Product Market Share by Players (2019-2024)
Table 18. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2023)
Table 19. Ranking of Global Top Blood Product Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Blood Product Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Blood Product Product Solution and Service
Table 23. Date of Enter into Blood Product Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Product Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Blood Product Revenue Market Share by Type (2019-2024)
Table 27. Global Blood Product Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Blood Product Revenue Market Share by Type (2025-2030)
Table 29. Global Blood Product Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Blood Product Revenue Market Share by Application (2019-2024)
Table 31. Global Blood Product Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Blood Product Revenue Market Share by Application (2025-2030)
Table 33. North America Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Blood Product Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Blood Product Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Blood Product Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Blood Product Product
Table 51. Takeda Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Blood Product Product
Table 56. CSL Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Blood Product Product
Table 61. Grifols Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Detail
Table 64. Octapharma Business Overview
Table 65. Octapharma Blood Product Product
Table 66. Octapharma Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Detail
Table 69. Kedrion Business Overview
Table 70. Kedrion Blood Product Product
Table 71. Kedrion Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Detail
Table 74. LFB Group Business Overview
Table 75. LFB Group Blood Product Product
Table 76. LFB Group Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Detail
Table 79. Biotest Business Overview
Table 80. Biotest Blood Product Product
Table 81. Biotest Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Detail
Table 84. BPL Business Overview
Table 85. BPL Blood Product Product
Table 86. BPL Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 87. BPL Recent Development
Table 88. Shanghai RAAS Company Detail
Table 89. Shanghai RAAS Business Overview
Table 90. Shanghai RAAS Blood Product Product
Table 91. Shanghai RAAS Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 92. Shanghai RAAS Recent Development
Table 93. China Biologic Products Company Detail
Table 94. China Biologic Products Business Overview
Table 95. China Biologic Products Blood Product Product
Table 96. China Biologic Products Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 97. China Biologic Products Recent Development
Table 98. Hualan Biological Engineering Inc. Company Detail
Table 99. Hualan Biological Engineering Inc. Business Overview
Table 100. Hualan Biological Engineering Inc. Blood Product Product
Table 101. Hualan Biological Engineering Inc. Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 102. Hualan Biological Engineering Inc. Recent Development
Table 103. Beijing Tiantan Biological Products Corp Company Detail
Table 104. Beijing Tiantan Biological Products Corp Business Overview
Table 105. Beijing Tiantan Biological Products Corp Blood Product Product
Table 106. Beijing Tiantan Biological Products Corp Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 107. Beijing Tiantan Biological Products Corp Recent Development
Table 108. Pacific Shuanglin Company Detail
Table 109. Pacific Shuanglin Business Overview
Table 110. Pacific Shuanglin Blood Product Product
Table 111. Pacific Shuanglin Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 112. Pacific Shuanglin Recent Development
Table 113. Boya Bio-Pharmaceutical Company Detail
Table 114. Boya Bio-Pharmaceutical Business Overview
Table 115. Boya Bio-Pharmaceutical Blood Product Product
Table 116. Boya Bio-Pharmaceutical Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 117. Boya Bio-Pharmaceutical Recent Development
Table 118. Paisi Feike Biology Pharmacy Co., Ltd. Company Detail
Table 119. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
Table 120. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product
Table 121. Paisi Feike Biology Pharmacy Co., Ltd. Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 122. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
Table 123. Xinjiang Deyuan Bioengineering Company Detail
Table 124. Xinjiang Deyuan Bioengineering Business Overview
Table 125. Xinjiang Deyuan Bioengineering Blood Product Product
Table 126. Xinjiang Deyuan Bioengineering Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 127. Xinjiang Deyuan Bioengineering Recent Development
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Detail
Table 129. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
Table 130. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product
Table 131. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 132. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
Table 133. Shenzhen Weiguang Company Detail
Table 134. Shenzhen Weiguang Business Overview
Table 135. Shenzhen Weiguang Blood Product Product
Table 136. Shenzhen Weiguang Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 137. Shenzhen Weiguang Recent Development
Table 138. Shanxi Kangbao Company Detail
Table 139. Shanxi Kangbao Business Overview
Table 140. Shanxi Kangbao Blood Product Product
Table 141. Shanxi Kangbao Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 142. Shanxi Kangbao Recent Development
Table 143. Nanyue Biopharming Corporation Ltd Company Detail
Table 144. Nanyue Biopharming Corporation Ltd Business Overview
Table 145. Nanyue Biopharming Corporation Ltd Blood Product Product
Table 146. Nanyue Biopharming Corporation Ltd Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 147. Nanyue Biopharming Corporation Ltd Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Product Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Blood Product Market Share by Type: 2023 VS 2030
Figure 3. Albumin Features
Figure 4. Immunoglobulin Features
Figure 5. Clotting Factor Features
Figure 6. Others Features
Figure 7. Global Blood Product Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Blood Product Market Share by Application: 2023 VS 2030
Figure 9. Bleeding Wound Case Studies
Figure 10. Immunodeficiency Case Studies
Figure 11. HBV Case Studies
Figure 12. Tetanus Case Studies
Figure 13. Rabies Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Others Case Studies
Figure 16. Blood Product Report Years Considered
Figure 17. Global Blood Product Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Blood Product Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Blood Product Market Share by Region: 2023 VS 2030
Figure 20. Global Blood Product Market Share by Players in 2023
Figure 21. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Blood Product Revenue in 2023
Figure 23. North America Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Blood Product Market Share by Country (2019-2030)
Figure 25. United States Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Blood Product Market Share by Country (2019-2030)
Figure 29. Germany Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Blood Product Market Share by Region (2019-2030)
Figure 37. China Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Blood Product Market Share by Country (2019-2030)
Figure 45. Mexico Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Blood Product Market Share by Country (2019-2030)
Figure 49. Turkey Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Takeda Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 52. CSL Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 53. Grifols Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 54. Octapharma Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 55. Kedrion Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 56. LFB Group Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 57. Biotest Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 58. BPL Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 59. Shanghai RAAS Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 60. China Biologic Products Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 61. Hualan Biological Engineering Inc. Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 62. Beijing Tiantan Biological Products Corp Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 63. Pacific Shuanglin Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 64. Boya Bio-Pharmaceutical Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 65. Paisi Feike Biology Pharmacy Co., Ltd. Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 66. Xinjiang Deyuan Bioengineering Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 67. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 68. Shenzhen Weiguang Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 69. Shanxi Kangbao Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 70. Nanyue Biopharming Corporation Ltd Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Clotting Factor
Table 5. Key Players of Others
Table 6. Global Blood Product Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Blood Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Blood Product Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Blood Product Market Share by Region (2019-2024)
Table 10. Global Blood Product Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Blood Product Market Share by Region (2025-2030)
Table 12. Blood Product Market Trends
Table 13. Blood Product Market Drivers
Table 14. Blood Product Market Challenges
Table 15. Blood Product Market Restraints
Table 16. Global Blood Product Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Blood Product Market Share by Players (2019-2024)
Table 18. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2023)
Table 19. Ranking of Global Top Blood Product Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Blood Product Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Blood Product Product Solution and Service
Table 23. Date of Enter into Blood Product Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Product Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Blood Product Revenue Market Share by Type (2019-2024)
Table 27. Global Blood Product Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Blood Product Revenue Market Share by Type (2025-2030)
Table 29. Global Blood Product Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Blood Product Revenue Market Share by Application (2019-2024)
Table 31. Global Blood Product Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Blood Product Revenue Market Share by Application (2025-2030)
Table 33. North America Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Blood Product Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Blood Product Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Blood Product Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Blood Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Blood Product Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Blood Product Market Size by Country (2025-2030) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Blood Product Product
Table 51. Takeda Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Blood Product Product
Table 56. CSL Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Blood Product Product
Table 61. Grifols Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Detail
Table 64. Octapharma Business Overview
Table 65. Octapharma Blood Product Product
Table 66. Octapharma Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Detail
Table 69. Kedrion Business Overview
Table 70. Kedrion Blood Product Product
Table 71. Kedrion Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Detail
Table 74. LFB Group Business Overview
Table 75. LFB Group Blood Product Product
Table 76. LFB Group Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Detail
Table 79. Biotest Business Overview
Table 80. Biotest Blood Product Product
Table 81. Biotest Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Detail
Table 84. BPL Business Overview
Table 85. BPL Blood Product Product
Table 86. BPL Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 87. BPL Recent Development
Table 88. Shanghai RAAS Company Detail
Table 89. Shanghai RAAS Business Overview
Table 90. Shanghai RAAS Blood Product Product
Table 91. Shanghai RAAS Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 92. Shanghai RAAS Recent Development
Table 93. China Biologic Products Company Detail
Table 94. China Biologic Products Business Overview
Table 95. China Biologic Products Blood Product Product
Table 96. China Biologic Products Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 97. China Biologic Products Recent Development
Table 98. Hualan Biological Engineering Inc. Company Detail
Table 99. Hualan Biological Engineering Inc. Business Overview
Table 100. Hualan Biological Engineering Inc. Blood Product Product
Table 101. Hualan Biological Engineering Inc. Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 102. Hualan Biological Engineering Inc. Recent Development
Table 103. Beijing Tiantan Biological Products Corp Company Detail
Table 104. Beijing Tiantan Biological Products Corp Business Overview
Table 105. Beijing Tiantan Biological Products Corp Blood Product Product
Table 106. Beijing Tiantan Biological Products Corp Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 107. Beijing Tiantan Biological Products Corp Recent Development
Table 108. Pacific Shuanglin Company Detail
Table 109. Pacific Shuanglin Business Overview
Table 110. Pacific Shuanglin Blood Product Product
Table 111. Pacific Shuanglin Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 112. Pacific Shuanglin Recent Development
Table 113. Boya Bio-Pharmaceutical Company Detail
Table 114. Boya Bio-Pharmaceutical Business Overview
Table 115. Boya Bio-Pharmaceutical Blood Product Product
Table 116. Boya Bio-Pharmaceutical Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 117. Boya Bio-Pharmaceutical Recent Development
Table 118. Paisi Feike Biology Pharmacy Co., Ltd. Company Detail
Table 119. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
Table 120. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product
Table 121. Paisi Feike Biology Pharmacy Co., Ltd. Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 122. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
Table 123. Xinjiang Deyuan Bioengineering Company Detail
Table 124. Xinjiang Deyuan Bioengineering Business Overview
Table 125. Xinjiang Deyuan Bioengineering Blood Product Product
Table 126. Xinjiang Deyuan Bioengineering Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 127. Xinjiang Deyuan Bioengineering Recent Development
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Detail
Table 129. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
Table 130. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product
Table 131. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 132. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
Table 133. Shenzhen Weiguang Company Detail
Table 134. Shenzhen Weiguang Business Overview
Table 135. Shenzhen Weiguang Blood Product Product
Table 136. Shenzhen Weiguang Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 137. Shenzhen Weiguang Recent Development
Table 138. Shanxi Kangbao Company Detail
Table 139. Shanxi Kangbao Business Overview
Table 140. Shanxi Kangbao Blood Product Product
Table 141. Shanxi Kangbao Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 142. Shanxi Kangbao Recent Development
Table 143. Nanyue Biopharming Corporation Ltd Company Detail
Table 144. Nanyue Biopharming Corporation Ltd Business Overview
Table 145. Nanyue Biopharming Corporation Ltd Blood Product Product
Table 146. Nanyue Biopharming Corporation Ltd Revenue in Blood Product Business (2019-2024) & (US$ Million)
Table 147. Nanyue Biopharming Corporation Ltd Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Product Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Blood Product Market Share by Type: 2023 VS 2030
Figure 3. Albumin Features
Figure 4. Immunoglobulin Features
Figure 5. Clotting Factor Features
Figure 6. Others Features
Figure 7. Global Blood Product Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Blood Product Market Share by Application: 2023 VS 2030
Figure 9. Bleeding Wound Case Studies
Figure 10. Immunodeficiency Case Studies
Figure 11. HBV Case Studies
Figure 12. Tetanus Case Studies
Figure 13. Rabies Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Others Case Studies
Figure 16. Blood Product Report Years Considered
Figure 17. Global Blood Product Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Blood Product Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Blood Product Market Share by Region: 2023 VS 2030
Figure 20. Global Blood Product Market Share by Players in 2023
Figure 21. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Blood Product Revenue in 2023
Figure 23. North America Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Blood Product Market Share by Country (2019-2030)
Figure 25. United States Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Blood Product Market Share by Country (2019-2030)
Figure 29. Germany Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Blood Product Market Share by Region (2019-2030)
Figure 37. China Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Blood Product Market Share by Country (2019-2030)
Figure 45. Mexico Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Blood Product Market Share by Country (2019-2030)
Figure 49. Turkey Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Blood Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Takeda Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 52. CSL Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 53. Grifols Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 54. Octapharma Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 55. Kedrion Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 56. LFB Group Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 57. Biotest Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 58. BPL Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 59. Shanghai RAAS Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 60. China Biologic Products Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 61. Hualan Biological Engineering Inc. Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 62. Beijing Tiantan Biological Products Corp Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 63. Pacific Shuanglin Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 64. Boya Bio-Pharmaceutical Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 65. Paisi Feike Biology Pharmacy Co., Ltd. Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 66. Xinjiang Deyuan Bioengineering Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 67. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 68. Shenzhen Weiguang Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 69. Shanxi Kangbao Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 70. Nanyue Biopharming Corporation Ltd Revenue Growth Rate in Blood Product Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232